Analytical Data
-
Gene name
AFUA_2G03830
- Application
-
Alternative Names
Allergen: Asp f 4
-
Species
Neosartorya fumigata
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60024
-
Expression Region
21-322aa
-
Molecular Weight
48.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AFUA_2G03830 is a gene identified in the filamentous fungus Aspergillus fumigatus, an organism known for its role as an opportunistic pathogen in humans, particularly in immunocompromised individuals. The research into AFUA_2G03830 is driven by the need to understand the molecular mechanisms underlying the pathogenicity of A. fumigatus, as well as its unique metabolic pathways that may offer potential targets for therapeutic intervention. Preliminary studies suggest that the protein product of AFUA_2G03830 may play a significant role in the fungal lifecycle, possibly influencing virulence, growth, or stress response under varying environmental conditions. By characterizing this recombinant protein, researchers aim to elucidate its biochemical properties, interactions with host factors, and its functional relevance in pathogenic processes. Such studies are crucial, given the increasing incidence of aspergillosis and the limited treatment options available, especially with the rise of antifungal resistance. Understanding the role of AFUA_2G03830 could lead to the identification of novel drug targets, ultimately contributing to more effective strategies for controlling A. fumigatus infections and enhancing patient outcomes.
